Clinical trial
Daily Monitoring of Respiratory Symptoms and Spirometry During ETI Treatment in Persons With Cystic Fibrosis.
NCT05599230 is registered in ClinicalTrials.gov with CHC Montlegia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Daily Monitoring of Respiratory Symptoms and Spirometry During ETI Treatment in Persons With Cystic Fibrosis.
- Lead sponsor
- CHC Montlegia
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2022
- Completion date
- November 30, 2022
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.